Literature DB >> 32512270

MicroRNA-665-3p attenuates oxygen-glucose deprivation-evoked microglial cell apoptosis and inflammatory response by inhibiting NF-κB signaling via targeting TRIM8.

Xiajing Zhang1, Yan Feng1, Jiangjing Li2, Ling Zheng1, Yongping Shao1, Fangyun Zhu1, Xude Sun3.   

Abstract

Microglial inflammation induced by ischemic stroke aggravates brain damage. MicroRNAs (miRNAs) have emerged as pivotal regulators in ischemic stroke-induced inflammation in microglial cells. miR-665-3p has been reported as a critical inflammation-associated miRNA. However, whether miR-665-3p participates in regulating microglial inflammation during ischemic stroke is underdetermined. This study investigated the potential role of miR-665-3p in stroke-induced inflammation in microglial cells using a cellular model of oxygen-glucose deprivation (OGD)-stimulated microglial cells in vitro. We found that miR-665-3p expression was decreased in microglial cells exposed to OGD treatment. Functional experiments demonstrated that the overexpression of miR-665-3p attenuated OGD-induced apoptosis and inflammation in microglial cells. Notably, tripartite motif 8 (TRIM8) was identified as a target gene of miR-665-3p. TRIM8 expression was induced by OGD treatment in microglial cells and the knockdown of TRIM8 protected microglial cells from OGD -induced cytotoxicity and inflammation. Moreover, TRIM8 knockdown or miR-665-3p overexpression blocked OGD-induced activation of nuclear factor (NF)-κB signaling in microglial cells. In addition, TRIM8 overexpression partially reversed the miR-665-3p overexpression-mediated inhibitory effect on OGD-induced inflammation in microglial cells. Taken together, these results indicate that miR-665-3p up-regulation protects microglial cells from OGD-induced apoptosis and inflammatory response by targeting TRIM8 to inhibit NF-κB signaling.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Inflammation; Microglia; NF-κB; TRIM8; miR-665-3p

Mesh:

Substances:

Year:  2020        PMID: 32512270     DOI: 10.1016/j.intimp.2020.106650

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

1.  MiR-665 Participates in the Protective Effect of Dexmedetomidine in Ischemic Stroke by ROCK2/NF-κB Axis.

Authors:  QiongHua Liu; JianE Wu; ShangShu Lai; Gan Li
Journal:  Neurochem Res       Date:  2022-05-10       Impact factor: 3.996

Review 2.  Hypoxic/Ischemic Inflammation, MicroRNAs and δ-Opioid Receptors: Hypoxia/Ischemia-Sensitive Versus-Insensitive Organs.

Authors:  Yimeng Chen; Yichen He; Shuchen Zhao; Xiaozhou He; Dong Xue; Ying Xia
Journal:  Front Aging Neurosci       Date:  2022-05-09       Impact factor: 5.702

3.  Inhibition of miR-665-3p Enhances Autophagy and Alleviates Inflammation in Fusarium solani-Induced Keratitis.

Authors:  Qunqin Guo; Yi Lin; Jianzhang Hu
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-01-04       Impact factor: 4.799

4.  MicroRNA-665-3p exacerbates nonalcoholic fatty liver disease in mice.

Authors:  Yuanjie Yu; Tian Tian; Shiyun Tan; Pengbo Wu; Yitian Guo; Ming Li; Mengjun Huang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

5.  Salidroside inhibits NLRP3 inflammasome activation and apoptosis in microglia induced by cerebral ischemia/reperfusion injury by inhibiting the TLR4/NF-κB signaling pathway.

Authors:  Jie Liu; Wei Ma; Cheng-Hao Zang; Guo-Dong Wang; Si-Jia Zhang; Hong-Jie Wu; Ke-Wei Zhu; Xiang-Lin Xiang; Chun-Yan Li; Kuang-Pin Liu; Jian-Hui Guo; Li-Yan Li
Journal:  Ann Transl Med       Date:  2021-11

6.  Upregulated LINC00319 aggravates neuronal injury induced by oxygen-glucose deprivation via modulating miR-200a-3p.

Authors:  Hui Yang; He Wang; Xiaodan Zhang; Yuehan Yang; Hongbin Li
Journal:  Exp Ther Med       Date:  2021-06-07       Impact factor: 2.447

Review 7.  Emerging Roles of TRIM8 in Health and Disease.

Authors:  Flaviana Marzano; Luisa Guerrini; Graziano Pesole; Elisabetta Sbisà; Apollonia Tullo
Journal:  Cells       Date:  2021-03-05       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.